Outlook for RNAi, 2007: siRNA and miRNA in biology, diagnostics and therapeutics

RNAi-based screens have provided new opportunities for the discovery and validation of novel therapeutic targets in areas such as cancer and infectious diseases. Since 2005, enormous strides have also been made in the development of RNAi-based therapeutic products, bringing them significantly closer to the market.

‘Outlook for RNAi 2007’ is a new report which provides a detailed insight into the most effective use of this novel technology in the drug discovery and development process. It puts into context where RNAi technology is being used as a tool of choice within academia and the pharma industry for functional genomic studies, drug target discovery and mechanism of action studies. The development status RNAi based therapeutics is covered in detail, highlighting the key companies in the field, outlining their pipelines and describing the results of completed clinical trials. Understand how RNAi technology is being used to improve drug attrition rates and develop new therapeutic agents, and ensure that you are up-to-date with developments in this advancing field.

Read more...

• The Anti-Infectives Market Outlook to 2013 (14/10/2008)
• Sales Outlook for Big Pharma (15/05/2008)
• CNS Market Outlook (15/05/2008)

• Protein Engineering & Drug Design (14/05/2008)
• Winning Product Launch Strategies (14/05/2008)
• Drug Repositioning Strategies (14/05/2008)

• Targeted Cancer Therapies (14/05/2008)
• The Future of Biosimilars (14/05/2008)
• Cardiovascular Disease Management (14/05/2008)
• Nanotechnology (12/05/2008)
• The Future of Targeted Therapeutics (12/05/2008)
• Nosocomial Vaccines (12/05/2008)
• HRT for Menopausal Symptoms (12/05/2008)
• CNS Market Overview (12/05/2008)

---